Company news

Racura Oncology Ltd news in 2018

Racura Oncology Ltd's news releases, calls and decks from 2018, newest first.

View company

Race signs agreement for Bisantrene NPP in Israel

December 16, 2018

Race appoints Biosynergy to pursue Bisantrene licensing

October 31, 2018

September 2018 Quarterly Report

October 25, 2018

Appendix 4E & Financial Statements

August 21, 2018

June 2018 Quarterly Report

July 26, 2018

FDA Grants Bisantrene Rare Paediatric Disease Designation

July 18, 2018

Bisantrene poster presented at French Leukaemia Conference

June 26, 2018

Bisantrene approval in UK for supply as unlicensed medicine

June 21, 2018

RAC cancer drug success in AML reported by French doctors

June 4, 2018

Race executes agreement for Bisantrene clinical trial

May 14, 2018

Race signs global distribution agreement with Durbin PLC

April 10, 2018

Race increases placement to $3.69m

March 16, 2018

Race completes over-subscribed $3.159 million placement

March 11, 2018

Second Bisantrene Patent Allowed in US

February 20, 2018

Notice of Allowance for Bisantrene Patent in US

January 28, 2018

Race Receives $170k R&D Tax Incentive Refund

January 24, 2018

Decks in 2018